dfwl28 wrote: The subject received several invest
Post# of 148151
The subject received several investigational treatments prior to treatment with leronlimab. Upon admission, the subject was treated with dexamethasone for 10 days. Remdesivir was initiated on Day 1; a plasma exchange was administered on Day 4 for 10 days. Other drug interventions included intravenous antibiotics. The subject’s condition continued to deteriorate, and ECMO was initiated on Day 19. Four doses of leronlimab (700 mg), obtained from CytoDyn (CytoDyn inc. WA, USA) through an Emergency Investigational New Drug (EIND) application, were administered on Days 79, 86 and 93 and 100 post diagnosis. The subject responded extremely rapidly and was weaned off ECMO between Days 82 to 84, and he was discharged from the ECMO intensive care unit on Day 91.
my response:
So why did this sick fellow on ECMO have to wait 79 days on the brink of death, to get the life saving drug leronlimab? In 3 days they start weening him off ECMO????? It reminds me of our share price which is presently waiting....on ECMO, just lingering, in the duldrums at $2.27, the EUA is in the hands of the FDA to give the SP life support, but they won't give it, and the reason is garbage.
This is pathetic. Lawsuits. Another Adam Fartsmudge attack today. SP red. We have a life saving drug. FDA farting on the toilet wiping with sandpaper spreading blood across America.